Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 552,023
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Phone: 415-670-2000
Jusprag24
Jusprag24 Aug. 19 at 7:08 PM
$QQQ Biotech and pharma is the new trade. Pound the table on $IBB
0 · Reply
Bio_investor_
Bio_investor_ Aug. 19 at 6:47 PM
$TGTX $AXSM $IBB $XBI One fine morning whoever shorted TGTX and AXSM will have same situation that MRNA shorts had today. Till then just enjoy holding or accumulating.
0 · Reply
TalkMarkets
TalkMarkets Aug. 19 at 6:22 PM
#Semis Down, #Biotech And #Bitcoin Up $IBB $SOXX $IBIT https://talkmarkets.com/article/semis-down-biotech-up-1787163592
0 · Reply
Bio_investor_
Bio_investor_ Aug. 19 at 6:06 PM
$TGTX $IBB $XBI Soon people will know why Mike never sold any of his 14M+ shares and only bought during open market. They trying to flush weak hand so those big players can be part of MRNA days when Sub-Q takes over the entire MS space.
0 · Reply
evanmedeiros
evanmedeiros Aug. 19 at 5:40 PM
Biotech $IBB all-time highs up and out of expanding Bollinger Bands
0 · Reply
EquityClock
EquityClock Aug. 19 at 5:22 PM
Loving the strength we are seeing in Pharmaceutical/Biotechnology stocks and Gold, both seasonally strong through the third quarter. We are benefiting. $IHE $IBB $GLD $GDX
0 · Reply
droptopfibonacci
droptopfibonacci Aug. 19 at 4:09 PM
$ALNY $VKTX $MRNA Looks like it might be time to start shopping for some pharma/biotech names with good upside $IBB
2 · Reply
william64
william64 Aug. 19 at 3:42 PM
$IBB after 5 years of underperformance looks like a real break. Don't chase today, imo, but get it on a pullback. Could last a long time.
0 · Reply
G_R_
G_R_ Aug. 19 at 2:44 PM
$CRSP $ARKG $IBB $XBI Massive moves in Biotech today...The signs were all there.
0 · Reply
atreus57
atreus57 Aug. 19 at 2:22 PM
$RNXT warrants are being misread as bearish dilution. They can actually let institutions take MORE economic exposure while controlling regulatory risk. RNXT’s warrants use 4.99%/9.99% ownership blockers. Why? At >5%, SEC Schedule 13D/13G reporting can apply. At >10%, Section 16 can bring insider reporting + 6-month short-swing profit restrictions. So an institution can buy common shares up to its chosen limit, then hold additional exposure through pre-funded/milestone warrants without being able to exercise past the blocker. That means: more capital committed to RNXT -> larger economic exposure -> ownership kept below key regulatory thresholds. This is not evidence investors want out. It is sophisticated financing plumbing that lets large investors participate without unnecessarily sacrificing liquidity and trading flexibility. Bullish distinction: warrants can represent institutional demand beyond what they want to hold immediately as common stock. $RNXT $XBI $IBB $LXRX
0 · Reply
Latest News on IBB
3 Healthcare ETFs to Own in a Choppy Stock Market

Jul 6, 2026, 2:04 PM EDT - 6 weeks ago

3 Healthcare ETFs to Own in a Choppy Stock Market

XLV XPH


BIO CEO says more consistency needed in FDA review process

Jun 23, 2026, 4:34 PM EDT - 2 months ago

BIO CEO says more consistency needed in FDA review process

BBH XHB


Biotech Investors Are Tuning Out the MAHA Chaos

May 20, 2026, 5:30 AM EDT - 3 months ago

Biotech Investors Are Tuning Out the MAHA Chaos

PJP XBI


Funding for Risky Biotechs Is Returning

Jan 12, 2026, 12:00 PM EST - 7 months ago

Funding for Risky Biotechs Is Returning

XBI


'Fast Money' traders talk how to play biopharma space

Nov 11, 2025, 6:56 PM EST - 10 months ago

'Fast Money' traders talk how to play biopharma space

XLV


Trade Tracker: Jason Snipe buys the IBB

Oct 17, 2025, 1:30 PM EDT - 10 months ago

Trade Tracker: Jason Snipe buys the IBB


Fast Money: WTI, IBB, UBER, CAT

Jun 13, 2025, 6:20 PM EDT - 1 year ago

Fast Money: WTI, IBB, UBER, CAT

UBER CAT


New vaccine chief rocks pharmaceutical stocks

May 7, 2025, 11:13 AM EDT - 1 year ago

New vaccine chief rocks pharmaceutical stocks

BNTX MRNA NVAX PFE GSK SRPT XBI


Sell into strength in pharma, says Mizuho's Jared Holz

Apr 11, 2025, 7:17 PM EDT - 1 year ago

Sell into strength in pharma, says Mizuho's Jared Holz

XBI


Final Trade: Euro, IBB, SMH, NEM

Nov 20, 2024, 6:21 PM EST - 1 year ago

Final Trade: Euro, IBB, SMH, NEM

SMH NEM


Analyst is 'extremely bullish' on biopharma

Jul 30, 2024, 3:25 PM EDT - 2 years ago

Analyst is 'extremely bullish' on biopharma

MRK PFE


Biotech's Next Gold Rush: Weight-Loss Drugs

Apr 2, 2024, 4:56 PM EDT - 2 years ago

Biotech's Next Gold Rush: Weight-Loss Drugs

LLY NVO


Jusprag24
Jusprag24 Aug. 19 at 7:08 PM
$QQQ Biotech and pharma is the new trade. Pound the table on $IBB
0 · Reply
Bio_investor_
Bio_investor_ Aug. 19 at 6:47 PM
$TGTX $AXSM $IBB $XBI One fine morning whoever shorted TGTX and AXSM will have same situation that MRNA shorts had today. Till then just enjoy holding or accumulating.
0 · Reply
TalkMarkets
TalkMarkets Aug. 19 at 6:22 PM
#Semis Down, #Biotech And #Bitcoin Up $IBB $SOXX $IBIT https://talkmarkets.com/article/semis-down-biotech-up-1787163592
0 · Reply
Bio_investor_
Bio_investor_ Aug. 19 at 6:06 PM
$TGTX $IBB $XBI Soon people will know why Mike never sold any of his 14M+ shares and only bought during open market. They trying to flush weak hand so those big players can be part of MRNA days when Sub-Q takes over the entire MS space.
0 · Reply
evanmedeiros
evanmedeiros Aug. 19 at 5:40 PM
Biotech $IBB all-time highs up and out of expanding Bollinger Bands
0 · Reply
EquityClock
EquityClock Aug. 19 at 5:22 PM
Loving the strength we are seeing in Pharmaceutical/Biotechnology stocks and Gold, both seasonally strong through the third quarter. We are benefiting. $IHE $IBB $GLD $GDX
0 · Reply
droptopfibonacci
droptopfibonacci Aug. 19 at 4:09 PM
$ALNY $VKTX $MRNA Looks like it might be time to start shopping for some pharma/biotech names with good upside $IBB
2 · Reply
william64
william64 Aug. 19 at 3:42 PM
$IBB after 5 years of underperformance looks like a real break. Don't chase today, imo, but get it on a pullback. Could last a long time.
0 · Reply
G_R_
G_R_ Aug. 19 at 2:44 PM
$CRSP $ARKG $IBB $XBI Massive moves in Biotech today...The signs were all there.
0 · Reply
atreus57
atreus57 Aug. 19 at 2:22 PM
$RNXT warrants are being misread as bearish dilution. They can actually let institutions take MORE economic exposure while controlling regulatory risk. RNXT’s warrants use 4.99%/9.99% ownership blockers. Why? At >5%, SEC Schedule 13D/13G reporting can apply. At >10%, Section 16 can bring insider reporting + 6-month short-swing profit restrictions. So an institution can buy common shares up to its chosen limit, then hold additional exposure through pre-funded/milestone warrants without being able to exercise past the blocker. That means: more capital committed to RNXT -> larger economic exposure -> ownership kept below key regulatory thresholds. This is not evidence investors want out. It is sophisticated financing plumbing that lets large investors participate without unnecessarily sacrificing liquidity and trading flexibility. Bullish distinction: warrants can represent institutional demand beyond what they want to hold immediately as common stock. $RNXT $XBI $IBB $LXRX
0 · Reply
howardlindzon
howardlindzon Aug. 19 at 2:14 PM
the case for biotech still a good read. shared it a few months back $XLV $XBI $IBB $ARKG
0 · Reply
WAJeff
WAJeff Aug. 19 at 1:45 PM
Pretty crazy to wake up to this $MRNA news. Had a sale go off at $115.51, also some $XBI selling at $166 and $IBB at 210.04 (aths for both) and 7/28 $MRK 134.76s selling at $147.06 ($149.26 ath). Bios on fire
0 · Reply
Stocktwits
Stocktwits Aug. 19 at 12:28 PM
$XBI $IBB Love it when @cfromhertz nails a trade! What a call!
0 · Reply
cfromhertz
cfromhertz Aug. 19 at 12:10 PM
$MRNA +100% $MRK +8% $MRNA is in $IBB $XBI / $MRK is in $XLV Moderna, Merck Shares Surge After Melanoma Vaccine Success (Bloomberg)
0 · Reply
SenefAS
SenefAS Aug. 19 at 11:30 AM
What a great news for the science $MRK and $MRNA personalized mRNA vaccine with Keytruda reduced melanoma recurrence in a 1,137-patient Phase 3 trial—the first late-stage win for an mRNA cancer vaccine $IBB $XBI
0 · Reply
HueySnow252
HueySnow252 Aug. 19 at 9:04 AM
$IBB $OXLC $GILD $HUT IBB provides diversified biotechnology exposure, Oxford Lane benefits from credit-market conditions, Gilead benefits from its pharmaceutical portfolio, and Hut 8 benefits from Bitcoin and data-center infrastructure demand. I'm watching biotech catalysts, credit spreads, drug sales, Bitcoin prices, and power capacity.
0 · Reply
WallStJesus
WallStJesus Aug. 18 at 6:20 PM
0 · Reply
WAJeff
WAJeff Aug. 18 at 2:49 PM
$IBB 203.87 ath
0 · Reply
robcarroll
robcarroll Aug. 18 at 1:49 PM
$SLS the dilution machine is out of fuel, and that changes the game for the shorts. For years, shorts covered into a steady drip of cheap new shares — warrant exercises and the ATM. That supply is nearly gone: the warrant overhang has collapsed from 58.5M to under 10M, and the $150M ATM sits completely untouched. So how do ~55M short shares get covered now? By buying in the open market — into a float where institutions hold ~45% and keep buying. That buying pushes price up, not down. The tool the shorts leaned on is gone. The drift into the 80th event has room to run. A multi-year move higher for $XBI and $IBB could really get things moving as the entire biotech M&A space heats up.
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 8:52 PM
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 17 at 7:01 PM
$OTLK Do you see $OTLK maybe going under 50 cents a share by the end of the year despite a July FDA approval? $REGN $ABBV $IBB
1 · Reply
LQQKER_INSIDER
LQQKER_INSIDER Aug. 17 at 11:34 AM
$XBI $IBB $SPY $IWM https://www.fiercebiotech.com/biotech/after-2-undisclosed-gene-therapy-deaths-can-china-iit-alternative-regulatory-path-still-be
0 · Reply